Puma Biotechnology | PBYI - Kreditur Perdagangan





Kreditur Perdagangan Perubahan Tanggal
Agios Pharmaceuticals USD 16.34M 2.6M 2026-06
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Amgen USD 2.86B 16.65B 2026-06
Biogen USD 403.9M 45.4M 2026-06
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Daiichi Sankyo JPY 539.05B 57.81B 2026-06
Exelixis USD 39.06M 14.91M 2026-06
Gilead Sciences USD 645M 70M 2026-03
Glaxosmithkline GBP 14.34B 6.39B 2026-03
Incyte USD 1.39B 1.16B 2026-06
MacroGenics USD 3.44M 845K 2026-06
Moderna USD 167M 6M 2026-06
Novartis USD 4.26B 64M 2026-06
Pfizer USD 4.58B 75M 2026-06
PTC Therapeutics USD 40.45M 14.96M 2026-06
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sarepta Therapeutics USD 50.98M 19.39M 2026-06
Takeda JPY 446.78B 44.56B 2026-06
TG Therapeutics USD 213.69M 64.85M 2026-06
Ultragenyx Pharmaceutical USD 39M 3M 2026-06
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12
Vertex Pharmaceuticals USD 3.61B 135M 2026-06